Publication date: Jun 22, 2022 Metastatic skin cutaneous melanomas that contain wild-type BRAF alleles (“BRAF WT melanomas”) remain a significant clinical challenge, primarily because of the paucity of targets for ... Read more

Publication date: Jun 23, 2022 Prospective multicentric study including women aged 18 to 35 and men aged 18 to 45 during their visit to centers for the study and storage ... Read more

Publication date: Jun 24, 2022 Burd says these models can be used to activate and study the role of NRAS is other relevant cancer types such as colon cancer, leukemia, ... Read more

Publication date: Jun 24, 2022 A NOVEL STUDY has found that consuming increased levels of fish appears to be associated with a greater risk of developing malignant melanoma. Though fish ... Read more

Publication date: Jun 24, 2022 Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy. Apatinib in combination with camrelizumab, a humanized immunoglobulin ... Read more

Publication date: Jun 22, 2022 The study will evaluate how safe the study drug is, how well you tolerate it, and how it works in the body and the disease’s ... Read more

Publication date: Jun 20, 2022 This study is a non-interventional retrospective observational study performed on secondary data from a German multi-site cohort registry, the German national registry of skin cancer ... Read more

Publication date: Jun 20, 2022 Metastatic skin cutaneous melanomas remain a significant clinical problem. In particular, those melanomas that do not contain a gain-of-function BRAF allele remain challenging to treat ... Read more

Publication date: Jun 21, 2022 Researchers found mutations across the genome that appear to contribute to tumor growth in 5-10% of cancer patients. The number of cryptic splice sites that ... Read more

Publication date: Jun 22, 2022 Second, it activates immune cells positively for better targeting of tumours. Concepts Keywords Australiarace Rehabilitation protocols Baker Education portal Ceo Coordinate manufacturing product Immunotherapy Concussion ... Read more